Cite

HARVARD Citation

    Obdeijn, I. et al. (2016). Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models. European journal of cancer. pp. 135-142. [Online]. 
  
Back to record